In prostate cancer, the CXCL12/CXCR4 axis is crucial for the initial establishment of bone metastases in the endosteal niche, which is severely compromised by the blockade of the CXCL12/CXCR4 axis [231]. Here, CXCR4 is linked to prostate carcinoma.